Tag: Vaccines
Therapeutic Vaccine Shows Preliminary Safety, Effectiveness for HPV16+ Cervical Precancerous Condition
50 percent of patients with CIN3 had histopathological complete response; 63 percent had HPV16 clearance
Parental Sociodemographics Linked to Child MMR Vaccine Uptake
MMR vaccination rates appear to be higher for children of parents who receive at least one dose of COVID-19 vaccine
Moderna Receives $590M From HHS to Develop Bird Flu Vaccine
Interviews ID Factors Tied to COVID-19 Vaccine Hesitancy in Black Women
Mistrust in health care and government, concerns over vaccine safety and long-term effects among top factors
FDA Adds Warning Label to RSV Vaccines Abrysvo and Arexvy
Postmarketing observation shows increased risk for Guillain-Barré syndrome for 42 days postvaccination
15.4 Percent of 0- to 35-Month-Olds Receive Invalid Vaccine Dose
Of children with minimum age or minimum interval invalid dose, almost 50 percent receive extra doses
Eight in 10 Infants Received RSV Protection in the 2023 to 2024 Season
Findings seen within a single health care system during the early period of availability
Immunocompromised Have Heterogeneous Antibody Response to RSV Vaccines
Median four-week preF IgG fold rise was 4.21; 61 percent of participants achieved seroconversion
Confidence in Vaccines Both Steady and Rising in U.S. Adults
Increases seen in acceptance for new respiratory syncytial virus vaccines
Influenza Vaccine Effective Against Severe Illness in Children
Vaccine effectiveness of 52.8 percent seen for ED visits, 52.3 percent for noncritical hospitalization, 50.4 percent for critical hospitalization
